12:00 AM
Jul 24, 2000
 |  BC Week In Review  |  Clinical News  |  Clinical Status

LE-AON: Began Phase I testing

NeoPharm Inc. (NEOL), Bannockburn, Ill.
Product: LE-AON
Business: Cancer
Therapeutic category: Antisense, Adjunct
Target: c- raf-1...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >